Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
Titel:
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
Auteur:
Portale, Anthony A. Carpenter, Thomas O. Brandi, Maria Luisa Briot, Karine Cheong, Hae II Cohen-Solal, Martine Crowley, Rachel Jan De Beur, Suzanne Eastell, Richard Imanishi, Yasuo Imel, Erik A. Ing, Steven Ito, Nobuaki Javaid, Muhammad Kamenicky, Peter Keen, Richard Kubota, Takuo Lachmann, Robin Perwad, Farzana Pitukcheewanont, Pisit Ralston, Stuart H. Takeuchi, Yasuhiro Tanaka, Hiroyuki Weber, Thomas J. Yoo, Han-Wook Zhang, Lin Theodore-Oklota, Christina Mealiffe, Matt San Martin, Javier Insogna, Karl